Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio, and platelet-lymphocyte ratio in stroke-associated pneumonia: a systematic review and meta-analysis

References

• Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439–448.
   PubMed Web of Science ®Google Scholar
• Kishore AK, Vail A, Chamorro A, et al. How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis. Stroke. 2015;46:1202–1209.
   PubMed Web of Science ®Google Scholar
• Hannawi Y, Hannawi B, Rao CPV, et al. Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis. 2013;35(5):430–443.
   PubMed Web of Science ®Google Scholar
• Suda S, Aoki J, Shimoyama T, et al. Stroke-associated infection independently predicts 3-month poor functional outcome and mortality. J Neurol. 2018;265(2):370–375.
   PubMed Web of Science ®Google Scholar
• Teh WH, Smith CJ, Barlas RS, et al. Impact of stroke‐associated pneumonia on mortality, length of hospitalization, and functional outcome. Acta Neurol Scand. 2018;138(4):293–300.
   PubMed Web of Science ®Google Scholar
• Xu C-Y, Ye H-W, Chen B, et al. Analysis of risk factors and prognosis of post-stroke pulmonary infection in integrated ICU. Eur Rev Med Pharmacol Sci. 2021;25(2):856–865.
   PubMed Web of Science ®Google Scholar
• Ni J, Shou W, Wu X, et al. Prediction of stroke-associated pneumonia by the A2DS2, AIS-APS, and ISAN scores: a systematic review and meta-analysis. Expert Rev Respir Med. 2021;15(11):1461–1472.
   PubMed Web of Science ®Google Scholar
• Harms H, Grittner U, Dröge H, et al. Predicting post‐stroke pneumonia: the PANTHERIS score. Acta Neurol Scand. 2013;128(3):178–184.
   PubMed Web of Science ®Google Scholar
• Quyet D, Hien NM, Khan MX, et al. Risk factors for stroke associated pneumonia. Open Access Maced J Med Sci. 2019;7(24):4416–4419.
   PubMedGoogle Scholar
• Kishore AK, Vail A, Bray BD, et al. Clinical risk scores for predicting stroke-associated pneumonia: a systematic review. Eur Stroke J. 2016;1(2):76–84.
   PubMedGoogle Scholar
• Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14.
   PubMedGoogle Scholar
• Huang Y, Liu A, Liang L, et al. Diagnostic value of blood parameters for community-acquired pneumonia. Int Immunopharmacol. 2018;64:10–15.
   PubMed Web of Science ®Google Scholar
• Kartal O, Kartal AT. Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia. Bratisl Lek Listy. 2017;118(9):513–516.
   PubMed Web of Science ®Google Scholar
• Üçsular F, Polat G, Karadeniz G, et al. Predictive value of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hypersensitivity pneumonia. Sarcoidosis, Vasc. Diffus. Lung Dis. 2020;37(4):e2020012.
   PubMed Web of Science ®Google Scholar
• Kumar P, Law S, Sriram KB. Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis. 2017;9(6):1509–1516.
   PubMed Web of Science ®Google Scholar
• Cao F, Wan Y, Lei C, et al. Monocyte‐to‐lymphocyte ratio as a predictor of stroke‐associated pneumonia: a retrospective study‐based investigation. Brain Behav. 2021;11(6):e02141.
   PubMed Web of Science ®Google Scholar
• Cheng H-R, Song JY, Zhang YN, et al. High monocyte-to-lymphocyte ratio is associated with stroke-associated pneumonia. Front. Neurol. 2020;11:575809.
   Web of Science ®Google Scholar
• Li W, He C. Association of platelet-to-lymphocyte ratio with stroke-associated pneumonia in acute ischemic stroke. J. Healthc. Eng. 2022;2022:1033332.
   Web of Science ®Google Scholar
• Qiu H, Song J, Hu J, et al. Low serum transthyretin levels predict stroke-associated pneumonia. Nutr Metab Cardiovasc Dis. 2022;32(3):632–640.
   PubMed Web of Science ®Google Scholar
• Gens R, Ourtani A, De Vos A, et al. Usefulness of the neutrophil-to-lymphocyte ratio as a predictor of pneumonia and urinary tract infection within the first week after acute ischemic stroke. Front. Neurol. 2021;12:747.
   Web of Science ®Google Scholar
• Chen L-Z, Xia H-W, Zhan L-Q, et al. Effect of thrombolytic therapy on high neutrophil-to-lymphocyte ratio in predicting stroke-associated pneumonia after acute ischemic stroke. 2022. DOI:10.21203/rs.3.rs-1509675/v1
   Google Scholar
• Cheng W, Chen L, Yu H, et al. Value of combining of the NLR and the fibrinogen level for predicting stroke-associated pneumonia. Neuropsychiatr Dis Treat. 2021;17:1697–1705.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Gao J, Lv Q, et al. Risk factors and outcomes of stroke-associated pneumonia in patients with stroke and acute large artery occlusion treated with endovascular thrombectomy. J Stroke Cerebrovasc Dis. 2020;29(11):105223.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhao W, Wu C, et al. SDL index predicts stroke-associated pneumonia in patients after endovascular therapy. Front. Neurol. 2021;12:622272.
   PubMed Web of Science ®Google Scholar
• Nam K-W, Kim TJ, Lee JS, et al. High neutrophil-to-lymphocyte ratio predicts stroke-associated pneumonia. Stroke. 2018;49(8):1886–1892.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Kishore AK, Vail A, et al. Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group. Stroke. 2015;46:2335–2340.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013.
   Google Scholar
• Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 2014;14:1–13.
   PubMed Web of Science ®Google Scholar
• Higgins JP. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www. cochrane-handbook. org 2011.
   Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Akkaif MA, Sha’aban A, Daud NAA, et al. Coronary heart disease (CHD) in elderly patients: which drug to choose, ticagrelor and clopidogrel? A systematic review and meta-analysis of randomized controlled trials. J. Cardiovasc. Dev. Dis. 2021;8:123.
   PubMed Web of Science ®Google Scholar
• Yu Y, Xia T, Tan Z, et al. A2DS2 score combined with clinical and neuroimaging factors better predicts stroke-associated pneumonia in hyperacute cerebral infarction. Front. Neurol. 2022;13:800614.
   Web of Science ®Google Scholar
• Xia G-H, Zhang MS, Wu QH, et al. Dysbiosis of gut microbiota is an independent risk factor of stroke-associated pneumonia: a Chinese pilot study. Front. Cell. Infect. Microbiol. 2021;11:715475.
   Web of Science ®Google Scholar
• Khanzadeh S, Lucke-Wold B, Eshghyar F, et al. The neutrophil to lymphocyte ratio in poststroke infection: a systematic review and meta-analysis. Dis Markers. 2022;2022:1983455.
   Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. Taylor & Francis; 2013.
   Google Scholar
• Sawilowsky SS. New effect size rules of thumb. J. Mod. Appl. Stat. methods. 2009;8:26.
   Google Scholar
• Li W, Hou M, Ding Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio in stroke: a systematic review and meta-analysis. Front. Neurol. 2021;12:686983.
   Web of Science ®Google Scholar
• Song S-Y, Zhao X-X, Rajah G, et al. Clinical significance of baseline neutrophil-to-lymphocyte ratio in patients with ischemic stroke or hemorrhagic stroke: an updated meta-analysis. Front Neurol. 2019;10:1032.
   PubMed Web of Science ®Google Scholar
• Kamel H, Iadecola C. Brain–immune interactions and ischemic stroke: clinical implications. Arch Neurol. 2012;69(5):576–581.
   PubMedGoogle Scholar
• Haeusler KG, Schmidt WUH, Föhring F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis. 2008;25(1–2):50–58.
   PubMed Web of Science ®Google Scholar
• Elkind MSV, Boehme AK, Smith CJ, et al. Infection as a stroke risk factor and determinant of outcome after stroke. Stroke. 2020;51(10):3156–3168.
   PubMed Web of Science ®Google Scholar
• Makris K, Haliassos A, Chondrogianni M, et al. Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research. Crit Rev Clin Lab Sci. 2018;55(5):294–328.
   PubMed Web of Science ®Google Scholar
• Geissmann F, Manz MG, Jung S, et al. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327:656–661.
   Google Scholar
• Garcia JH, Liu KF, Yoshida Y, et al. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am. J. Pathol. 1994;144(1):188–199.
   Web of Science ®Google Scholar
• Urra X, Cervera A, Obach V, et al. Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke. 2009;40(4):1262–1268.
   PubMed Web of Science ®Google Scholar
• Harms H, Prass K, Meisel C, et al. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLOS One. 2008;3(5):e2158.
   PubMed Web of Science ®Google Scholar
• Klehmet J, Harms H, Richter M, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience. 2009;158(3):1184–1193.
   PubMed Web of Science ®Google Scholar
• Vogelgesang A, Grunwald U, Langner S, et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke. 2008;39(1):237–241.
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 2007;100(1):27–40.
   PubMed Web of Science ®Google Scholar